Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
MEDIORG
MEDIORG

Medicamen Organics Ltd.

NSE: MEDIORG
SME
Sector: Healthcare
Industry: Pharmaceuticals
24.55-0.9 (-3.54%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
36.53
P/E (TTM)
-
P/B
1.27
P/S (TTM)
1.61
EV/EBITDA
-
CAPE (5Y)
35.65
ROE (TTM)
-13.66
ROCE (TTM)
-10.85
ROA (TTM)
-7.25
Avg 3Y ROE
8.11
Earnings 3Y CAGR
-73.08
Sales 3Y CAGR
0.72
Sales 5Y CAGR
-2.01
Debt/Equity
0.50
Consensus TP
-
Strong Buy %
-
Promoter Holding
54.89
Pledged %
0.00

Share Price

Track Medicamen Organics Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: -8.22 %
Low
24.5
High
25.5
1 Month returns: 6.74 %
Low
22.9
High
26.8
1 Year returns: -32.92 %
Low
19.1
High
37.9
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Medicamen Organics Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Medicamen Organics Ltd. Shareholding Pattern

Quarterly breakdown of Medicamen Organics Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Medicamen Organics Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Medicamen Organics Ltd.?
The current share price of Medicamen Organics Ltd. is ₹ 24.55 as of 23 Oct 2026.
What is the market capitalisation of Medicamen Organics Ltd.?
The market capitalisation of Medicamen Organics Ltd. stands at ₹ 36.53 Cr.
What is the PE ratio of Medicamen Organics Ltd.?
The Price-to-Earnings (PE) ratio of Medicamen Organics Ltd. is - as of the latest trailing twelve months data.
What is the ROE and ROCE of Medicamen Organics Ltd.?
Medicamen Organics Ltd. has a Return on Equity (ROE) of -13.66% and a Return on Capital Employed (ROCE) of -10.85% as per the latest financial reports.
What is the 52-week high and low of Medicamen Organics Ltd.?
The 52-week high of Medicamen Organics Ltd. is - and the 52-week low is -.
What is the dividend yield of Medicamen Organics Ltd.?
The dividend yield of Medicamen Organics Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Medicamen Organics Ltd.?
Foreign Institutional Investors (FII) hold 0.05%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 43.18% of Medicamen Organics Ltd. shares.
What sector does Medicamen Organics Ltd. belong to?
Medicamen Organics Ltd. operates in the Healthcare sector.
What is the beta of Medicamen Organics Ltd.?
The beta of Medicamen Organics Ltd. is 0.94, indicating its price volatility relative to the broader market.
What is the RSI of Medicamen Organics Ltd.?
The 14-day Relative Strength Index (RSI) of Medicamen Organics Ltd. is 49.73, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.